Literature DB >> 26481483

Incidence and therapeutic frequency of extrahepatic collateral arteries in transcatheter arterial chemoembolization of hepatocellular carcinoma: Experience from 182 patients with survival time more than 3 years.

Qiang Li1, Guo-Kun Ao2, Feng Duan3, Zhi-Jun Wang4, Jie-Yu Yan5, Mao-Qiang Wang6.   

Abstract

PURPOSE: To retrospectively evaluate the incidence of each extrahepatic collateral artery (EHCA) supplying to hepatocellular carcinoma (HCC) in sessions of transcatheter arterial chemoembolization (TACE) and its therapeutic frequency.
MATERIALS AND METHODS: Between February 2002 and May 2008, 182 patients with HCC underwent TACE and survived more than 3 years. For TACE procedure, angiographic evaluation of all suspected EHCAs that could supply the tumor were performed. The incidence of EHCAs in TACE sessions and therapeutic frequency were analyzed. Correlations between the number of collaterals and the number of TACE sessions were investigated.
RESULTS: 162 patients showed 647 EHCAs supplying tumors in a total of 795 sessions of TACE. The initially confirmed EHCAs in TACE sessions were the right inferior phrenic artery (RIPA, n=150), left inferior phrenic artery (LIPA, n=8), right internal mammary artery (RIMA, n=4), right adrenal artery (RAA, n=2) and left gastric artery (LGA, n=5), respectively. The incidences of EHCAs were 51.1%, 68.1%, 50.0%, 50.0%, 42.3%, 34.6%, 29.1%, 19.8%, 6.6%, 3.3% and 0.6% from 1 to 11 session of TACE, respectively. The RIPA was accounted for 62.5% of EHCAs and other EHCAs often occurred after the attenuation of RIPA. There were correlations between the number of TACE sessions and either the sum number of collaterals (r=-0.961; p<0.001), the number of RIPA(r=-0.948; p<0.001) or the number of LGA(r=-0.670; p=0.024). The mean therapeutic frequencies of TACE were 2.6, 1.5, 1.6, 1.3, 1.5, 1.2, 3.3, 1.1, 1.0 and 7.0 times for the RIPA, LIPA, RIMA, left internal mammary artery (LIMA), omental artery (OMA), LGA, right intercostal artery (RICA), RAA, right renal capsular artery (RRCA) and colic artery (COA), respectively.
CONCLUSIONS: The RIPA angiography should be routinely performed in TACE procedure. EHCAs should be searched during the sessions of TACE in the following order: RIPA, RIMA, LIPA and other collaterals of lower incidence.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Angiography; Blood supply; Extrahepatic collateral artery; Hepatocellular carcinoma; Transcatheter arterial chemoembolization

Mesh:

Year:  2015        PMID: 26481483     DOI: 10.1016/j.ejrad.2015.10.006

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  8 in total

1.  Hepatocellular Carcinoma With Different Areas of Right Retroperitoneal Space Invasion: Evaluation of Transcatheter Arterial Chemoembolization Efficacy and Blood Supply Characteristics.

Authors:  Xi Liu; Guangsheng Liao; Xiaoping Luo; Wenlong Song; Haiping Zhang; Hao Chen; Shangzhi Cai; Dajing Guo
Journal:  Front Oncol       Date:  2020-09-23       Impact factor: 6.244

2.  A comprehensive study of right and left inferior phrenic artery variations in 1000 patients with multidetector computed tomography angiography: an important study for HCC.

Authors:  Arzu Ekingen; Mehmet Güli Çetinçakmak
Journal:  Surg Radiol Anat       Date:  2021-07-23       Impact factor: 1.246

3.  Chemoembolization for hepatocellular carcinoma fed by right internal thoracic artery.

Authors:  Tao Shen; Zhongzhi Jia; Yuanquan Huang; Shaoqin Li; Guomin Jiang; Lihua Cheng
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

4.  Rational design of temperature-sensitive blood-vessel-embolic nanogels for improving hypoxic tumor microenvironment after transcatheter arterial embolization.

Authors:  Ling Li; Yiming Liu; Han Li; Xiaopeng Guo; Xiaojun He; Shinan Geng; Hao Zhao; Xiaole Peng; Dingwen Shi; Bin Xiong; Guofeng Zhou; Yanbing Zhao; Chuansheng Zheng; Xiangliang Yang
Journal:  Theranostics       Date:  2018-11-29       Impact factor: 11.556

5.  Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.

Authors:  Yanqiao Ren; Yanyan Cao; Hong Ma; Xuefeng Kan; Chen Zhou; Jiacheng Liu; Qin Shi; Gansheng Feng; Bin Xiong; Chuansheng Zheng
Journal:  BMC Cancer       Date:  2019-10-22       Impact factor: 4.430

6.  Combined Ultrasound and CT-Guided Iodine-125 Seeds Implantation for Treatment of Residual Hepatocellular Carcinoma Located at Complex Sites After Transcatheter Arterial Chemoembolization.

Authors:  Yanqiao Ren; Xiangjun Dong; Lei Chen; Tao Sun; Osamah Alwalid; Xuefeng Kan; Yangbo Su; Bin Xiong; Huimin Liang; Chuansheng Zheng; Ping Han
Journal:  Front Oncol       Date:  2021-03-02       Impact factor: 6.244

7.  Assessment of the embolization effect of temperature-sensitive p(N-isopropylacrylamide-co-butyl methylacrylate) nanogels in the rabbit renal artery by CT perfusion and confirmed by macroscopic examination.

Authors:  Zhen Zhang; Chunyuan Cen; Kun Qian; Han Li; Xin Zhang; Hongsen Zhang; Guina Ma; Yan Chen; Nanchuan Jiang; Chuansheng Zheng; Yanbing Zhao; Ping Han
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379

8.  Hypoxic targeting and activating TH-302 loaded transcatheter arterial embolization microsphere.

Authors:  Pengkai Ma; Jianhua Chen; Haixian Qu; Ye Li; Xiaohui Li; Xuemei Tang; Zhigang Song; Hainan Xin; Jinbang Zhang; Jingxue Nai; Zhiping Li; Zhijun Wang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.